Conceptual proposal introduces adaptive coherence modulators to enhance mental health by restoring neuro-coherence.
For over half a century, the standard of care in severe psychiatric disorders has relied on the chronic suppression of neurochemical activity. While effective at arresting acute manic or psychotic divergence, these static interventions function as permanent external governors. They effectively dampen phase variance (Δ_GR) but often at the severe cost of the patient’s neuroplastic gain (Γ) and thermodynamic stability (Θ), leading to states of metabolic exhaustion and chemical dependency. This manuscript proposes a foundational paradigm shift away from chronic suppression, formally introducing the conceptual architecture for a new pharmacological class: Adaptive Coherence Modulators (ACMs). Proposed as state-dependent "Neuro-Coherence Scaffolds," ACMs represent a theoretical model for finite, temporally sequenced intervention. By utilizing wave-native computational geometries and mathematically optimized bivalent scaffolding (Multi-Target-Directed Ligands), this framework redefines conditions such as Bipolar I, Schizophrenia, and Treatment-Resistant Depression not as static chemical imbalances, but as distinct topological failures within a systemic Neuro-Coherence Function (ℳ). Key Concepts Introduced: The Neuro-Coherence Restoration Cycle (NCRC): A three-phase pharmacodynamic sequence transitioning from acute variance damping to resonant tutoring and, ultimately, adaptive release. Systemic Independence: The ultimate theoretical objective of the ACM architecture—intentional pharmacological obsolescence where the biological infrastructure is repaired so the external scaffold can be permanently tapered. Wave-Native In Silico Design: A theoretical computational blueprint for engineering dynamic molecules that respect the localized energetic, thermodynamic, and oscillatory state of the neural tissue. Multimodal Biomarker Falsifiability: A proposed clinical matrix (utilizing High-Density EEG, fMRS, and fMRI) to objectively separate true systemic restoration from conventional chemical suppression. This document serves as a conceptual proposal and theoretical blueprint, establishing prior art for the future of physics-informed, open-source psychopharmacology.
No takes yet. Share an insight, caveat, or question.
Don Feeney (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: